Literature DB >> 15933756

Alterations of the RB1 gene in dedifferentiated liposarcoma.

Tomonari Takahira1, Yoshinao Oda, Sadafumi Tamiya, Hidetaka Yamamoto, Chikashi Kobayashi, Teiyu Izumi, Kensaku Ito, Yukihide Iwamoto, Masazumi Tsuneyoshi.   

Abstract

Dedifferentiated liposarcoma is a malignant adipocytic neoplasm containing a non-lipogenic sarcoma of variable histological grade that arises against the background of a pre-existing well-differentiated liposarcoma. The phenomenon of dedifferentiation is considered to be time-dependent, but the mechanism is not well known. The retinoblastoma protein, encoded by the RB1 gene located at 13q14, is a key regulator of proliferation, development, and differentiation of certain cell types, including adipocytes. In the current study, we investigated the genetic alterations of the RB1 gene, such as mutation (the essential promoter region and the protein-binding pocket domain; exons 20-24) and methylation of the promoter region, in addition to pRB expression and loss of heterozygosity (LOH) status, in two morphologically distinct areas (non-lipogenic dedifferentiated and well-differentiated components) in 27 patients. As a control, 11 undifferentiated high-grade pleomorphic sarcoma/pleomorphic malignant fibrous histiocytoma samples and 11 well-differentiated liposarcoma samples were also evaluated. Dedifferentiated components showed LOH (15/25; 60%) and abnormal retinoblastoma protein expression (18/27; 66.7%) more frequently than noted in the well-differentiated components (3/24; 12.5% and 9/27; 33.3%, respectively). Five and four out of the 27 dedifferentiated components harbored mutations and promoter methylation, respectively, whereas none of these alterations were seen in the well-differentiated components. These results suggest that retinoblastoma protein has a major role to play in dedifferentiation and that a 'two-hit' mechanism is involved in the altered retinoblastoma protein expression in dedifferentiated liposarcoma. .Modern Pathology (2005) 18, 1454-1460. doi:10.1038/modpathol.3800444; published online 20 May 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933756     DOI: 10.1038/modpathol.3800447

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  11 in total

1.  CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest.

Authors:  Ashleigh M Francis; Angela Alexander; Yanna Liu; Smruthi Vijayaraghavan; Kwang Hui Low; Dong Yang; Tuyen Bui; Neeta Somaiah; Vinod Ravi; Khandan Keyomarsi; Kelly K Hunt
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

Review 2.  Liposarcoma: a soft tissue tumor with many presentations.

Authors:  H J Mankin; K P Mankin; D C Harmon
Journal:  Musculoskelet Surg       Date:  2014-07-22

3.  Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma.

Authors:  Atsushi Yamashita; Yoshiyuki Suehara; Takuo Hayashi; Tatsuya Takagi; Daisuke Kubota; Keita Sasa; Nobuhiko Hasegawa; Muneaki Ishijima; Takashi Yao; Tsuyoshi Saito
Journal:  Virchows Arch       Date:  2022-06-15       Impact factor: 4.535

4.  Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.

Authors:  Kenichi Kohashi; Yoshinao Oda; Hidetaka Yamamoto; Sadafumi Tamiya; Tomonari Takahira; Yukiko Takahashi; Tatsuro Tajiri; Tomoaki Taguchi; Sachiyo Suita; Masazumi Tsuneyoshi
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

5.  Inhibition of P53-mediated cell cycle control as the determinant in dedifferentiated liposarcomas development.

Authors:  Mossane Stocker; Louis-Romée Le Nail; Hubert De Belenet; Jay S Wunder; Irene L Andrulis; Nalan Gokgoz; Nicolas Levy; Jean-Camille Mattei; Sylviane Olschwang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

6.  Genomic profiling reveals subsets of dedifferentiated liposarcoma to follow separate molecular pathways.

Authors:  Ralf J Rieker; Juergen Weitz; Burkhard Lehner; Gerlinde Egerer; Andrea Mueller; Bernd Kasper; Peter Schirmacher; Stefan Joos; Gunhild Mechtersheimer
Journal:  Virchows Arch       Date:  2009-12-29       Impact factor: 4.064

7.  Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.

Authors:  Stefan C Dentro; Ignaty Leshchiner; Kerstin Haase; Maxime Tarabichi; Jeff Wintersinger; Amit G Deshwar; Kaixian Yu; Yulia Rubanova; Geoff Macintyre; Jonas Demeulemeester; Ignacio Vázquez-García; Kortine Kleinheinz; Dimitri G Livitz; Salem Malikic; Nilgun Donmez; Subhajit Sengupta; Pavana Anur; Clemency Jolly; Marek Cmero; Daniel Rosebrock; Steven E Schumacher; Yu Fan; Matthew Fittall; Ruben M Drews; Xiaotong Yao; Thomas B K Watkins; Juhee Lee; Matthias Schlesner; Hongtu Zhu; David J Adams; Nicholas McGranahan; Charles Swanton; Gad Getz; Paul C Boutros; Marcin Imielinski; Rameen Beroukhim; S Cenk Sahinalp; Yuan Ji; Martin Peifer; Inigo Martincorena; Florian Markowetz; Ville Mustonen; Ke Yuan; Moritz Gerstung; Paul T Spellman; Wenyi Wang; Quaid D Morris; David C Wedge; Peter Van Loo
Journal:  Cell       Date:  2021-04-07       Impact factor: 41.582

8.  An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.

Authors:  Tingsheng Peng; Pingyu Zhang; Jeffery Liu; Theresa Nguyen; Svetlana Bolshakov; Roman Belousov; Eric D Young; Xiaoke Wang; Kari Brewer; Delores H López-Terrada; Andre M Oliveira; Alexander J Lazar; Dina Lev
Journal:  Lab Invest       Date:  2010-11-08       Impact factor: 5.662

Review 9.  Beyond What Your Retina Can See: Similarities of Retinoblastoma Function between Plants and Animals, from Developmental Processes to Epigenetic Regulation.

Authors:  Estephania Zluhan-Martínez; Vadim Pérez-Koldenkova; Martha Verónica Ponce-Castañeda; María de la Paz Sánchez; Berenice García-Ponce; Sergio Miguel-Hernández; Elena R Álvarez-Buylla; Adriana Garay-Arroyo
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

Review 10.  The Rapidly Expanding Group of RB1-Deleted Soft Tissue Tumors: An Updated Review.

Authors:  Sasha Libbrecht; Jo Van Dorpe; David Creytens
Journal:  Diagnostics (Basel)       Date:  2021-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.